(19)

(11)

EP 4 823 539 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24828122.2 (22) Date of filing: 11.12.2024

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 9/19(2006.01) A61K 47/18(2017.01) A61K 38/48(2006.01) A61K 9/08(2006.01) A61K 47/02(2006.01) A61K 47/26(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/19; A61K 9/08; A61K 9/0019; A61K 47/183; A61K 38/4893; A61K 47/26; A61K 47/02; C12Y 304/24069; A61K 8/64; A61K 8/4946; A61K 8/0216; A61Q 19/00 (86) International application number: PCT/GB2024/053076 (87) International publication number: WO 2025/125793 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 11.12.2023 GB 202318884 (71) Applicant: Ipsen Biopharm Limited Wrexham LL13 9UF (GB)	(72) Inventors: SHUBBER, Saif Wrexham Industrial Estate Wrexham LL13 9UF (GB) KELLY, Robert Wrexham Industrial Estate Wrexham LL13 9UF (GB) (74) Representative: Carpmaels & Ransford LLP  One Southampton Row London WC1B 5HA London WC1B 5HA (GB)